Helix Announces $50M Series C Funding To Continue Acceleration Into Clinical Population Genomics And Covid-19 Viral Surveillance

by prnewswire.com posted 3weeks ago 12 views
SAN MATEO, Calif., June 3, 2021 /PRNewswire/ -- Helix, the leading population genomics and COVID-19 testing company, has closed on its Series C funding round led by existing investors Warburg Pincus, DFJ Growth, Kleiner Perkins Caufield Byers, Mayo Clinic and Temasek. The $50M round will...

In this article

No tags related to this article.